Those facts were confirmed in animal models of IGF-I deficiency as they often exhibit increased ROS production and decreased NO bioavailability, mimicking the vascular aging phenotype[294]. This evidence concerns the gene IGF1 and hyperinsulinemic hypoglycemia, familial, 4.